✦ LIBER ✦

Treatment of stage II cutaneous T-cell lymphoma with interferon alfa-2a and extracorporeal photochemotherapy: A prospective controlled trial

✍ Scribed by Uwe Wollina; Annette Looks; Jochen Meyer; Burkhard Knopf; Hans-Jürgen Koch; Kristin Liebold; Uta-Christina Hipler

Book ID: 117844799
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 118 KB
Volume: 44
Category: Article
ISSN: 1097-6787
DOI: 10.1067/mjd.2001.110645

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of Cutaneous T Cell Lymphoma S

Treatment of Cutaneous T Cell Lymphoma Stage II with Interferon-α-2a and Extracorporeal Photochemotherapy : A Prospective Controlled Trial

✍ U. WOLLINA; A. LOOKS; J. MEYER; B. KNOPF; H.-J. KOCH; K. LIEBOLD; U.-C. HIPLER 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB

Role of extracorporeal photochemotherapy

Role of extracorporeal photochemotherapy alone and in combinationwith interferon alfa in the treatment of cutaneous T-cell lymphoma

✍ Michele Fimiani; Pietro Rubegni; Giovambattista De Aloe; Lucio Andreassi 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 214 KB

Extracorporeal photochemotherapy (ECP) g

Extracorporeal photochemotherapy (ECP) given with interferon (IFN)-α-2a seems to be effective in stage IIa cutaneous T cell lymphoma

📂 Article 📅 2001 🏛 Adis International Limited (now part of Wolters Kl ⚖ 151 KB

Results of a Phase II trial of oral bexa

Results of a Phase II trial of oral bexarotene (Targretin) combined with interferon alfa-2b (Intron-A) for patients with cutaneous T-cell lymphoma

✍ David J. Straus; Madeleine Duvic; Timothy Kuzel; Steven Horwitz; Marie-France De 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

## Abstract ## BACKGROUND. Bexarotene is one of the most active single agents for the treatment of recurring or refractory cutaneous T‐cell lymphoma (CTCL). Interferon alfa has also been used for many years as an effective treatment for this disease. The results in recent case reports of the combi

Survival of Patients with Cutaneous T Ce

Survival of Patients with Cutaneous T Cell Lymphoma after Treatment with Extracorporeal Photochemotherapy : A Retrospective Single-center Analysis

✍ U. WOLLINA; K. LIEBOLD; M. KAATZ; A. LOOKS; A. STUHLERT; D. LANGE 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 147 KB

Phase II trial of interferon-α-2a plus p

Phase II trial of interferon-α-2a plus psolaren with ultraviolet light A in patients with cutaneous T-cell lymphoma

✍ Vanna Chiarion-Sileni; Antonio Bononi; Cleto Veller Fornasa; Mariella Soraru; Ma 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB

## Purpose: To evaluate the efficacy and side effects of psolaren with ultraviolet light a (puva) and interferon-alpha-2a (ifn-alpha-2a) in patients with mycosis fungoides (mf) and sézary syndrome (ss). ## Patients and methods: From may 1993 to january 1999, 63 symptomatic patients with all stage